NOW ENROLLING FOR IRB-APPROVED STUDIES: PEDIATRIC ANEMIA & OBESITY |CALL 305-681-3111
NOW ENROLLING FOR IRB-APPROVED STUDIES: PEDIATRIC ANEMIA & OBESITY |CALL 305-681-3111
Eastern Research Inc. is currently enrolling eligible participants for a newly approved clinical research study scheduled to begin mid-February at our Hialeah, Florida location.
This study is intended for patients from birth to under 18 years of age with iron deficiency anemia, either due to non–dialysis-dependent chronic kidney disease or for those who are intolerant of or unresponsive to oral iron therapy.
The study has been reviewed and approved by an Institutional Review Board (IRB) and will be conducted in accordance with FDA regulations and Good Clinical Practice (GCP) guidelines.
This clinical research study focuses on iron deficiency anemia in pediatric patients from birth to under 18 years of age. The study includes patients with iron deficiency anemia due to non–dialysis-dependent chronic kidney disease, as well as patients with iron deficiency anemia who are intolerant of or unresponsive to oral iron therapy.
The purpose of this study is to advance medical knowledge while ensuring participant safety and high-quality care. Participation is voluntary, and all study-related activities are overseen by experienced, board-certified investigators and a highly trained clinical research team.
Eligible participants may receive study-related evaluations at no cost. Compensation and additional study details will be discussed during the screening process, if applicable.
- Contribute to the advancement of medical research
- Receive care from an experienced clinical research team
- Participate in a study conducted under FDA and GCP guidelines
If you would like to learn more or find out if your child may qualify for this study, please contact our office directly. A member of our research team will be happy to assist you and answer any questions.
📞 Call us at: (305) 681-3111
📍 Location: Hialeah, Florida
Participation is voluntary. This study has been approved by an Institutional Review Board (IRB). Eligibility criteria apply. No medical benefit or outcome is guaranteed.
Eastern Research, Inc. is currently enrolling eligible adults in the CorEvitas™ Obesity Drug Effectiveness and Safety Registry (OBR) — an IRB-approved observational research study designed to better understand obesity and the real-world use of medications prescribed for its treatment.
This is a prospective observational registry. Treatment decisions are made by your healthcare provider as part of routine clinical care. The study does not assign medications or alter your prescribed treatment.
The registry is designed to better understand how obesity progresses and how approved medications perform in real-world settings, including safety, effectiveness, and patient experience.
You may qualify if you:
Participation includes providing informed consent, completing electronic questionnaires, and allowing information from your routine medical care to be collected for research purposes. No additional visits beyond standard care are required.
Participation is voluntary, and you may withdraw at any time.
Call 305-681-3111 to speak with our research team and see if you may qualify.


This IRB-approved observational study was successfully conducted at Eastern Research, Inc. We thank all participants for their valuable contributions to advancing the understanding of atopic dermatitis through real-world research. Eastern Research continues enrolling in other IRB-approved studies.
Begin with an initial screening to determine if you meet the eligibility criteria for the study. Our team will guide you through this process and answer any questions you may have.
Once you're eligible, you'll undergo a physical assessment to ensure you’re in good health and ready to participate in the trial. Our medical professionals will provide all the necessary care and monitoring.
After completing the necessary assessments, you can begin participating in the clinical trial. You'll receive regular check-ups and care throughout the study, with ongoing support from our research team.
Click below to learn more about our enrolling studies and find out if you're eligible to participate.

Are you struggling with persistent sadness, loss of interest, or fatigue? You may qualify for a clinical trial evaluating new treatment options for depression.
🔹 No cost to participate
🔹 Compensation may be available
🔹 Confidential and professional care

Do you experience constant worry, nervousness, or difficulty relaxing? Our clinical trial is testing innovative treatments for generalized anxiety disorder (GAD).
🔹 Study-related care at no cost
🔹 Compensation for your time may be available
🔹 Help advance anxiety treatment options

Do you or a loved one experience memory loss, confusion, or difficulty completing familiar tasks? Our clinical trial is investigating potential treatments for Alzheimer’s disease.
🔹 Study-related care and medication at no cost
🔹 Compensation may be provided
🔹 Contribute to groundbreaking Alzheimer’s research
Copyright © 2026 Eastern Research Trials - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.